Wyeth pledges more than 40 million IUs of factor concentrates to WFH

As part of its continued commitment to hemophilia care around the world, Wyeth, now a part of Pfizer, has pledged more than 40 million international units (IUs) of factor concentrates to the World Federation of Hemophilia (WFH). This is the largest donation ever made to the WFH's Humanitarian Aid Program, and will make a significant impact to advance the WFH's goals.

"This donation will directly support building sustainable national care programs for people with bleeding disorders," said Mark Skinner, WFH president. "We are very proud to work with Wyeth, which has historically been the largest single donor of hemophilia products to the WFH."

The donation will bring life-saving treatment to many people with hemophilia around the world who would not otherwise have access to adequate treatment. Notably, participants of the WFH Twinning Program will receive some of the donated product which will help improve their quality of life. It will also support adults and young children who have no access to treatment and patients with life-threatening bleeding episodes.

"We are committed to working with partner organizations to provide access to hemophilia medicines to patients who need them," said Geno Germano, president and general manager of the Specialty Care Business Unit at Pfizer.

This donation and Wyeth's ongoing commitment will continue to strengthen the WFH's Humanitarian Aid program and will help provide those in need with valuable and life-saving medicines.

Source:

World Federation of Hemophilia

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
COVID-19 increases risk of bleeding, DVT, and pulmonary embolism